Divestiture • Life Science

Zentiva Acquires Alvogen CEE

On October 25, 2019, Zentiva acquired life science company Alvogen CEE from Alvogen

Acquisition Context
  • This is Zentiva’s 1st transaction in the Life Science sector.
  • This is Zentiva’s 1st transaction in Poland.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date October 25, 2019
Target Alvogen CEE
Sector Life Science
Buyer(s) Zentiva
Sellers(s) Alvogen
Deal Type Divestiture

Target Company

Alvogen CEE

Poland
Alvogen CEE markets over 200 generic and over-the-counter products across multiple therapeutic areas, consisting of highly recognized brands like Lactacyd, Persen, EuBiotic and many more with leading market positions in 14 key markets across CEE including; Russia, Romania, Bulgaria, Hungary, Poland and Balkan markets.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Zentiva

Prague, Czech Republic

Category Company
Sector Life Science
DESCRIPTION

Zentiva is a generics pharmaceutical company, offering generic medicines across all key therapeutic areas. Zentiva is based in Prague, Czech Republic.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Divestiture 1 of 1
Country: Poland 1 of 1
Year: 2019 1 of 1

Seller Profile 1

SELLER

Alvogen

Pine Brook, New Jersey, United States

Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing, and distributing generic, brand, over-the-counter brands (OTC), and biosimilar products. Alvogen was founded in 2009 and is based in Pine Brook, New Jersey.


Deal Context for Seller #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Divestiture 1 of 1
Country: Poland 1 of 1
Year: 2019 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-15 Omega Bittner

Moskva, Russia

Omega Bittner is a pharmaceutical firm. Omega Bittner is based in Moskva, Russia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-13 Assertio Therapeutics - Gralise Business

Newark, California, United States

Assertio Therapeutics, Inc. - Gralise Business is a prescription medicine used to treat pain after shingles, or postherpetic neuralgia (PHN).

Buy $128M

Explore Related M&A Activity